Key result
The 2014 ESC HCM-Risk-SCD score was evaluated for its effectiveness in predicting appropriate implantable-cardioverter-defibrillator shocks.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Use of the 2014 ESC HCM-Risk-SCD score for ICD decisions requires caution; leaves open need for prospective validation in larger cohorts.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Buongiorno et al. (2023) studied this question. The 2014 ESC HCM-Risk-SCD score was evaluated for its effectiveness in predicting appropriate implantable-cardioverter-defibrillator shocks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: